Hologic (HOLX) PT Boosted to $37 at Leerink Partners Amid 'Strong' Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) Tops Q2 EPS by 2c, Raises FY15 Guidance
April 29, 2015 5:04 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $655.5 million versus the consensus estimate of $646.49 million.
Hologic sees FY2015 EPS of $1.57-$1.59, versus prior guidance of $1.54-$1.57 and the consensus of $1.57. Hologic... More



